Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
Elena Sánchez‐López(Instituto de Salud Carlos III), María L. García(Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona), Amanda Cano(Biomedical Research Networking Center on Neurodegenerative Diseases), Marta Espina(Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona), Miren Ettcheto(Instituto de Salud Carlos III), Ana Cristina Calpena(Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona), Eliana B. Souto(Universidade do Porto), Antoni Camins(Biomedical Research Networking Center on Neurodegenerative Diseases), Nuria Carmona-Ule(Universitat de Barcelona), María Antonia Egea(Universitat de Barcelona), Amélia M. Silva(University of Trás-os-Montes and Alto Douro)
Cited by 284
Related Papers
Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
|Nanomaterials|2020|1.4k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery
|International Journal of Pharmaceutics|2004|664
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
|Journal of Controlled Release|2019|330
Microemulsions and Nanoemulsions in Skin Drug Delivery
|Bioengineering|2022|291